|
FY2026
12 months to Jun 27, 2026
|
FY2025
12 months to Jun 28, 2025
|
FY2024
12 months to Jun 29, 2024
|
FY2023
12 months to Jul 1, 2023
|
FY2022
12 months to Jul 2, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research, development and engineering expenses | |||||
| Selling, general and administrative expenses | |||||
| Gain on insurance proceeds, net of losses | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Interest expense, net | |||||
| Loss before income taxes | |||||
| Income tax provision (benefit) | |||||
| Net loss | |||||
| Net loss per share — Basic (in dollars per share) | |||||
| Weighted average shares outstanding — Basic (in shares) | |||||
| Net loss per share — Diluted (in dollars per share) | |||||
| Weighted average shares outstanding — Diluted (in shares) | |||||
Loading...
